Testing a new inhaler for COPD symptoms
Part of Lungs & breathing clinical trials.
This trial tests two forms of a new medication (HSK39004) in people with COPD. The goal is to see if they help improve breathing and are safe. Eligible participants must be between 40 and 80, have moderate to severe COPD, and be able to stop other COPD treatments during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 40 and 80 years old.
- You must have a COPD diagnosis confirmed by a breathing test (spirometry) within the last year.
- Your breathing test must show that your lung function is between 30% and 80% of normal for your age.
- Your COPD must have been stable (no flare-ups) for at least 4 weeks before screening.
- You must be able to stop using other COPD medications during the study (except for the rescue inhaler provided).
- You must be a current or former smoker with at least a 10 pack-year smoking history (like smoking 1 pack a day for 10 years), or have another significant risk factor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with COPD to check if an investigational inhaled powder (called HSK39004) is safe and works well over the long term. It may help you breathe better and manage your symptoms.
This study tests whether a new inhaled medication called HSK39004 can help people with COPD breathe better and reduce shortness of breath. You'll receive either the medication or a placebo (inactive powder) and be monitored for safety and effectiveness.
This trial tests an inhaled medication for COPD. It aims to see if the treatment is safe and helps improve breathing and symptoms.
This study tests a new inhaled medication called HSK39004 for people with COPD. The goal is to see if it is safe and effective over the long term, and to compare it with a placebo to find out how well it helps with breathing.
This study tests an experimental drug for people with moderate to severe COPD, especially those with chronic bronchitis. It aims to see how the drug affects certain markers in your body and whether it helps with your COPD symptoms.
This is an early-stage study testing a new inhaled medication (HRS-9821) to see if it is safe and how the body processes it. Researchers will first test it in healthy volunteers, then in people with COPD (chronic lung disease) to understand if it might help with breathing.
Hear when a new Chronic Obstructive Lung Disease (COLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.